NHWD-870 HCl

NHWD-870 HCl · Zhejiang Wenda Pharma Technology LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NHWD-870 HCl, covering 2025-01-24 to 2025-01-24. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer [Phase 2]

See pricing